Status:
UNKNOWN
Efficacy of tDCS on Pain in Multiple Sclerosis
Lead Sponsor:
University Hospital of Ferrara
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Pain is a common symptom experienced by people with MS and can significantly interfere with participation in the activities of daily living and adversely affect health-related quality of life. Pain in...
Eligibility Criteria
Inclusion
- chronic pain defined as a constant or intermittent sensory symptom with unpleasant feelings or pain, lasting more than 3 months with a minimum score of 3 points on the Numeric Rating Scale (NRS) for pain perception;
- lack of MS worsening in the three months just before the intervention period;
- cognitive functioning to give informed consent identified by a Mini-Mental Status Examination (MMSE) score ≥ 24/30.
Exclusion
- worsening of MS-related conditions or changes in drug therapy or any other confounding factor during the study;
- rehabilitation treatments or Botulinum toxin injections during the three months preceding the start of the study;
- intracranial metal implants that can be stimulated, incorrectly positioned, or overheated by the electric current;
- severe cardiopulmonary, renal, and hepatic diseases;
- pregnancy.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03389217
Start Date
December 1 2017
End Date
May 1 2023
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ferrara University Hospital
Ferrara, Italy, 44124